Astrana Health (NASDAQ:ASTH) Posts Quarterly Earnings Results, Misses Estimates By $0.46 EPS

Astrana Health (NASDAQ:ASTH) posted its quarterly earnings data on Thursday. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46), Zacks reports. The business had revenue of $956.05 million during the quarter, compared to analyst estimates of $952.83 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. Astrana Health’s revenue for the quarter was up 99.7% on a year-over-year basis. During the same quarter last year, the business earned $0.33 earnings per share. Astrana Health updated its FY 2025 guidance to EPS.

Astrana Health Stock Performance

Astrana Health stock traded down $7.83 during trading hours on Friday, hitting $25.53. The company had a trading volume of 1,200,236 shares, compared to its average volume of 347,454. The firm has a 50-day moving average of $30.44 and a 200 day moving average of $27.93. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The firm has a market cap of $1.43 billion, a PE ratio of 50.06, a PEG ratio of 0.90 and a beta of 0.80. Astrana Health has a one year low of $21.20 and a one year high of $57.42.

Hedge Funds Weigh In On Astrana Health

Large investors have recently made changes to their positions in the company. Tower Research Capital LLC TRC increased its position in Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares during the period. State of Wyoming bought a new stake in Astrana Health during the second quarter worth about $132,000. WINTON GROUP Ltd acquired a new stake in Astrana Health during the second quarter worth about $233,000. Brevan Howard Capital Management LP bought a new position in Astrana Health in the 2nd quarter valued at about $277,000. Finally, Jones Financial Companies Lllp increased its holdings in Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after buying an additional 10,913 shares during the period. Institutional investors own 52.77% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on ASTH. BTIG Research decreased their target price on shares of Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research report on Friday. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $47.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.